Protocol tips
Upstream tips |
Protocol tips |
Downstream tips |
|
siRNA oligonucleotides were purchased from Dharmacon [catalogue number M‐009136‐02 (Smart pool) and MU‐009136‐02 (set of four Upgrade siRNA duplexes) for human ARAP1, LOC361617 for rat ARAP1 and D‐001810‐10 for ON‐TARGETplus siCONTROL non‐targeting pool] and transfected using Oligofectamine (Invitrogen), according to the manufacturer’s instructions. The four oligonucleotides present in the pool that were also tested separately were 1 (5′‐GAGAAGGAGUGGCCUAUUA‐3′), 2 (5′‐GCAGGGAUCUUACAUCUAU‐3′), 3 (5′‐GGAGAUCACUGCCAUUGUG‐3′) and 4 (5′‐ACAAGAAUCUAGAGGAGUA‐3′).A significant reduction in ARAP1 levels was obtained after 72 h siRNAs treatment in HeLa cells (80 ± 5%) and after 48 h in NRK cells (70 ± 7%). All the experiments reported were performed in HeLa cells using the Smart pool of the four oligonucleotides and then repeated with at least two different single oligonucleotides (mainly 1 and 4). |
|
Protocol tips |
siRNA oligonucleotides were purchased from Dharmacon [catalogue number M‐009136‐02 (Smart pool) and MU‐009136‐02 (set of four Upgrade siRNA duplexes) for human ARAP1, LOC361617 for rat ARAP1 and D‐001810‐10 for ON‐TARGETplus siCONTROL non‐targeting pool] and transfected using Oligofectamine (Invitrogen), according to the manufacturer’s instructions. The four oligonucleotides present in the pool that were also tested separately were 1 (5′‐GAGAAGGAGUGGCCUAUUA‐3′), 2 (5′‐GCAGGGAUCUUACAUCUAU‐3′), 3 (5′‐GGAGAUCACUGCCAUUGUG‐3′) and 4 (5′‐ACAAGAAUCUAGAGGAGUA‐3′).A significant reduction in ARAP1 levels was obtained after 72 h siRNAs treatment in HeLa cells (80 ± 5%) and after 48 h in NRK cells (70 ± 7%). All the experiments reported were performed in HeLa cells using the Smart pool of the four oligonucleotides and then repeated with at least two different single oligonucleotides (mainly 1 and 4). |
Publication protocol
siRNA oligonucleotides were purchased from Dharmacon [catalogue number M‐009136‐02 (Smart pool) and MU‐009136‐02 (set of four Upgrade siRNA duplexes) for human ARAP1, LOC361617 for rat ARAP1 and D‐001810‐10 for ON‐TARGETplus siCONTROL non‐targeting pool] and transfected using Oligofectamine (Invitrogen), according to the manufacturer’s instructions. The four oligonucleotides present in the pool that were also tested separately were 1 (5′‐GAGAAGGAGUGGCCUAUUA‐3′), 2 (5′‐GCAGGGAUCUUACAUCUAU‐3′), 3 (5′‐GGAGAUCACUGCCAUUGUG‐3′) and 4 (5′‐ACAAGAAUCUAGAGGAGUA‐3′).A significant reduction in ARAP1 levels was obtained after 72 h siRNAs treatment in HeLa cells (80 ± 5%) and after 48 h in NRK cells (70 ± 7%). All the experiments reported were performed in HeLa cells using the Smart pool of the four oligonucleotides and then repeated with at least two different single oligonucleotides (mainly 1 and 4).
Full paper
Login or
join for free to view the full paper.
Reviews
siGENOME Human ARAP1 (116985) siRNA - SMARTpool from Horizon Discovery Ltd. has not yet been reviewed for this experiment
We'd love it if you would be the first to write a review!
Discussion
Start your discussion
Share your thoughts or question with experts in your field
Start a discussion
Papers
Check out relevant papers found by Labettor's AI that are relevant for performing siRNA / miRNA gene silencing Human - HeLa ARAP1 using siGENOME Human ARAP1 (116985) siRNA - SMARTpool from Horizon Discovery Ltd..
Manufacturer protocol
Download the product protocol from Horizon Discovery Ltd. for siGENOME Human ARAP1 (116985) siRNA - SMARTpool below.
Download manufacturer protocol
Videos
Check out videos that might be relevant for performing siRNA / miRNA gene silencing Human - HeLa ARAP1 using siGENOME Human ARAP1 (116985) siRNA - SMARTpool from Horizon Discovery Ltd.. Please note that these videos are representative and steps or experiment specific processes must be kept in mind to expect desired results.
We haven't found any additional videos for this experiment / product combination yet.